Your browser doesn't support javascript.
loading
Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post-remission treatment for children with very high-risk philadelphia chromosome negative B-cell acute lymphoblastic leukaemia in first complete remission.
Xue, Yu-Juan; Suo, Pan; Huang, Xiao-Jun; Lu, Ai-Dong; Wang, Yu; Zuo, Ying-Xi; Yan, Chen-Hua; Wu, Jun; Kong, Jun; Zhang, Xiao-Hui; Chen, Yu-Hong; Jia, Yue-Ping; Liu, Kai-Yan; Han, Wei; Xu, Lan-Ping; Zhang, Le-Ping; Cheng, Yi-Fei.
Afiliação
  • Xue YJ; Department of Paediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Suo P; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Huang XJ; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Lu AD; Department of Paediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Wang Y; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Zuo YX; Department of Paediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Yan CH; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Wu J; Department of Paediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Kong J; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Zhang XH; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Chen YH; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Jia YP; Department of Paediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Liu KY; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Han W; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Xu LP; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Zhang LP; Department of Paediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Cheng YF; Department of Haematology, National Clinical Research Centre for Haematological Disease, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
Br J Haematol ; 188(5): 757-767, 2020 03.
Article em En | MEDLINE | ID: mdl-31725190
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China